Prestige Consumer Healthcare  logo
Prestige Consumer Healthcare PBH
$ 61.72 0.47%

Quarterly report 2025-Q3
added 11-06-2025

report update icon

Prestige Consumer Healthcare Financial Statements 2011-2025 | PBH

Annual Financial Statements Prestige Consumer Healthcare

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

4.12 B 3.5 B 3.03 B 3.05 B 2.83 B 2.06 B 1.53 B 1.56 B 3.04 B 3 B 2.05 B 1.73 B 1.36 B 854 M 578 M

Shares

49.7 M 49.8 M 49.9 M 50.3 M 50.2 M 50.7 M 52.1 M 53.1 M 53 M 52.8 M 52.2 M 51.6 M 50.6 M 50.3 M 50.1 M

Historical Prices

82.8 70.3 60.8 60.8 56.5 40 40.6 27.9 41.3 52.1 46.1 33.8 29.9 21.2 12.7

Net Income

215 M 209 M -82.3 M 205 M 165 M 142 M -35.8 M 340 M 69.4 M 99.9 M 78.3 M 72.6 M 65.5 M 37.2 M 29.2 M

Revenue

1.14 B 1.13 B 1.13 B 1.09 B 943 M 963 M 976 M 1.04 B 882 M 806 M 715 M 602 M 624 M 441 M 337 M

Cost of Revenue

503 M 501 M 502 M 466 M 396 M 411 M 420 M 465 M 382 M 339 M - - - - -

Gross Profit

634 M 624 M 625 M 621 M 547 M 552 M 556 M 577 M 500 M 467 M 406 M 340 M 347 M 227 M 171 M

Operating Income

337 M 342 M -22.4 M 330 M 297 M 291 M 67.5 M 215 M 206 M 260 M 208 M 189 M 192 M 103 M 76.1 M

Interest Expense

1.8 M 5.2 M -2.34 M -1.05 M 1.37 M -1.62 M -476 K 392 K -30 K - - - - - -

EBITDA

367 M 373 M 10.2 M 362 M 328 M 316 M 323 M 244 M 283 M 284 M 225 M 202 M 205 M 114 M 86 M

Operating Expenses

298 M 282 M 648 M 291 M 250 M 261 M 260 M 361 M 243 M 207 M 199 M 151 M 155 M 125 M 94.7 M

General and Administrative Expenses

108 M 106 M 107 M 107 M 83.1 M 89.1 M 89.8 M 185 M 89.1 M 72.4 M 81.3 M 48.5 M 51.5 M 56.7 M 42 M

All numbers in USD currency

Quarterly Income Statement Prestige Consumer Healthcare

2025-Q3 2025-Q2 2024-Q4 2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

49 M 49.5 M 49.6 M 49.7 M 49.9 M 49.7 M 49.7 M 49.8 M - 49.7 M 49.8 M 50.3 M - 50.3 M 50.2 M 50.2 M - 50.2 M 50.2 M 50.3 M 50.4 M 50.4 M 50.4 M 50.5 M 51.7 M 51.9 M 51.9 M 51.8 M 53.1 M 53.1 M 53.1 M 53 M 53 M 53 M 53 M 53 M 52.9 M 52.8 M 52.8 M 52.8 M 52.5 M 52.3 M 52.3 M 52.1 M 52 M 51.8 M 51.8 M 51.5 M 51.2 M 50.7 M 50.7 M 50.4 M 50.3 M 50.3 M 50.3 M 50.3 M 50.2 M

Net Income

42.2 M 47.5 M 61 M 54.4 M 49.1 M 53 M 53.6 M 53.3 M - 52 M 51 M 55.3 M - 50.2 M 153 M 103 M - 40.9 M 40.9 M 44.6 M 37 M 38.1 M 38.1 M 33.3 M 33.9 M 38.2 M 38.2 M 30.8 M -39.7 M 315 M 30.7 M 33.8 M 33.8 M 31.6 M 31.6 M 32.2 M -5.53 M 28 M 28 M 31.8 M 26.2 M 21.3 M 21.3 M 16.5 M 16.7 M 3.13 M 3.13 M 32.8 M 20.7 M 12.3 M 12.3 M 19.2 M 14.7 M 9.51 M 9.51 M 12.9 M 14.8 M

Revenue

274 M 250 M 290 M 284 M 267 M 283 M 286 M 279 M - 276 M 289 M 277 M - 274 M 820 M 545 M - 239 M 239 M 237 M 251 M 242 M 242 M 238 M 232 M 241 M 241 M 254 M 256 M 271 M 258 M 257 M 241 M 217 M 217 M 215 M 210 M 200 M 200 M 206 M 192 M 198 M 198 M 181 M 146 M 145 M 145 M 167 M 143 M 160 M 160 M 162 M 147 M 106 M 106 M 106 M 95.3 M

Cost of Revenue

123 M 109 M 129 M 126 M 121 M 125 M 126 M 125 M - 125 M 128 M 117 M - 119 M 348 M 229 M - 99.9 M 99.9 M 99.8 M 107 M 104 M 104 M 101 M 98.1 M 102 M 102 M 102 M 115 M 123 M 114 M 113 M 113 M 92.2 M 92.2 M 91.1 M 88 M - - - - - - - - - - - - - - - - - - - -

Gross Profit

152 M 140 M 161 M 157 M 146 M 158 M 160 M 155 M - 150 M 161 M 160 M - 155 M 472 M 317 M - 139 M 139 M 138 M 144 M 137 M 137 M 137 M 134 M 139 M 139 M 137 M 141 M 148 M 144 M 143 M 143 M 125 M 125 M 124 M 122 M 117 M 117 M 120 M 112 M 112 M 112 M 103 M 81.9 M 80.5 M 80.5 M 93.2 M 83 M 85 M 85 M 90.5 M 83.6 M 55.1 M 55.1 M 53.9 M 49.9 M

Operating Income

79.7 M 71.8 M 92 M 84.3 M 72 M 86.8 M 88.2 M 85.2 M - 87.2 M 84.4 M 87 M - 82.6 M 252 M 170 M - 73.4 M 73.4 M 72.9 M 73.9 M 76.4 M 76.4 M 69.3 M 71.5 M 77.5 M 77.5 M 70.9 M -23.1 M 83.9 M 75.7 M 79 M 79 M 69.3 M 69.3 M 71.1 M 12.2 M 62.6 M 62.6 M 69.9 M 62.5 M 57 M 57 M 46.5 M 42.8 M 40.5 M 40.5 M 53.8 M 49.4 M 46.7 M 46.7 M 51.2 M 43.8 M 23.6 M 23.6 M 29.4 M 27.2 M

Interest Expense

-501 K 224 K -353 K -395 K -496 K -682 K -229 K 1.24 M - -1.15 M -812 K -825 K - -177 K -565 K -388 K - 371 K 371 K 259 K -930 K 580 K 580 K -859 K -416 K -218 K -218 K -335 K 273 K -387 K 432 K 74 K 74 K -18.6 M -20.8 M -21.1 M -23.1 M -19.5 M -20.7 M -21.9 M -23.8 M -24.6 M -18.2 M -14.7 M -15 M -21.3 M -16.4 M -15.9 M -18.2 M -26.7 M -19.7 M -19.8 M -16.3 M -8.12 M -8.28 M -8.58 M -

EBITDA

84.2 M 79.4 M 96.2 M 89.1 M 80.2 M 91.7 M 93.2 M 92.7 M - 92.8 M 90 M 95.4 M - 88 M 276 M 185 M - 78.3 M 96.1 M 87.9 M 73.9 M 81.3 M 98.1 M 83.6 M 78.5 M 82.8 M 102 M 87.3 M -23.1 M 89.7 M 81.5 M 87.5 M 79 M 70.6 M 88 M 83.9 M 12.2 M 63.8 M 80.1 M 81.3 M 62.5 M 58 M 69 M 53.3 M 42.8 M 41.6 M 50.7 M 60.3 M 49.4 M 47.1 M 56.7 M 57.7 M 43.8 M 23.8 M 31.3 M 34.5 M 27.2 M

Operating Expenses

71.9 M 68.6 M 69.1 M 73 M 74 M 71.1 M 71.8 M 69.5 M - 63.2 M 76.6 M 73.1 M - 72.5 M 219 M 147 M - 65.4 M 65.4 M 64.8 M 70 M 61.1 M 61.1 M 67.4 M 62.6 M 61.7 M 61.7 M 66.5 M 164 M 63.8 M 68.4 M 64.5 M 64.5 M 55.3 M 55.3 M 52.9 M 109 M 54.1 M 54.1 M 50 M 49.7 M 54.8 M 54.8 M 56 M 39.1 M 40 M 40 M 39.5 M 33.6 M 38.3 M 38.3 M 39.4 M 39.8 M 31.5 M 31.5 M 24.5 M 22.6 M

General and Administrative Expenses

28 M 28.5 M 26.2 M 26.1 M 28.9 M 26 M 26 M 27.7 M - 26.5 M 26.4 M 26.7 M - 26 M 80.7 M 54.7 M - 21.4 M 21.4 M 20.4 M 23.6 M 21.3 M 21.3 M 22.5 M 21.7 M 20.5 M 20.5 M 24 M 22.2 M 20.8 M 22 M 20.4 M 20.4 M 22.1 M 22.1 M 18.8 M 19.5 M 18.1 M 18.1 M 16.5 M 17.6 M 19.5 M 19.5 M 27.1 M 17 M 12.1 M 12.1 M 11.6 M 11.6 M 11.4 M 11.4 M 12.6 M 16.2 M 13.7 M 13.7 M 8.86 M 9.85 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Prestige Consumer Healthcare PBH
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Prestige Consumer Healthcare plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical distribution industry

Issuer Price % 24h Market Cap Country
AmerisourceBergen Corporation AmerisourceBergen Corporation
ABC
- -0.23 % $ 37.5 B usaUSA
Cardinal Health Cardinal Health
CAH
$ 199.57 0.71 % $ 48.1 B usaUSA
PPD, Inc. PPD, Inc.
PPD
- 0.13 % $ 16.6 B usaUSA
Henry Schein Henry Schein
HSIC
$ 77.33 1.03 % $ 9.8 B usaUSA
McKesson Corporation McKesson Corporation
MCK
$ 822.75 1.11 % $ 132 B usaUSA
Owens & Minor Owens & Minor
OMI
$ 3.01 -0.17 % $ 231 M usaUSA
Patterson Companies Patterson Companies
PDCO
- -0.87 % $ 3 B usaUSA